Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not (ERMIT)

NCT04927949 PHASE4 COMPLETED

This study aims to evaluate the impact on myocardial reperfusion and residual thrombotic burden of adding Cangrelor -a potent and immediate P2Y12 inhibitor- to ticagrelor in primary PCI patients with high on ticagrelor platelet reactivity compared to standard of care with ticagrelor alone.

Details

Lead sponsor	University Hospital, Caen
Phase	PHASE4
Status	COMPLETED
Enrolment	128
Start date	Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Mar 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• ST-elevation Myocardial Infarction

Interventions

• cangrelor perfusion during PCI
• standard PCI

Countries

France